Global Artificial Intelligence in Cancer Diagnostics Market Report 2022 to 2030: Players Include Pfizer, Therapixel, Sophia Genetics and Freenome

The global Artificial Intelligence in Cancer Diagnostics Market size is expected to reach USD 4,841.84 million by 2030. The report gives a detailed insight into current market dynamics and provides an analysis of future market growth.

Company Profiles

To detect abnormal cell growth in the body, AI can be used. AI and ML can identify the growth of cancer cells at an early stage with the help of machine learning. Furthermore, with the rising need for cancer detection at an early stage with efficacy, AI technologies are introduced and are expected to have a positive impact on the industry’s growth.

In addition, the rising prevalence of cancer worldwide is one of the primary drivers of the industry. AI is being used to detect cancer with efficacy and efficiency, detecting, classifying, and monitoring tumors, leading to industry growth.

The COVID-19 pandemic had a negative impact on the demand for AI in cancer diagnosis owing to the increasing number of COVID-19 cases during the period. Due to the increased number of Covid-19 cases, the healthcare sector was mainly focusing on those cases only.

Artificial Intelligence in Cancer Diagnostics Market Report Highlights

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Artificial Intelligence in Cancer Diagnostics Market Insights
4.1. Artificial Intelligence in Cancer Diagnostics – Industry Snapshot
4.2. Artificial Intelligence in Cancer Diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Rate of Accuracy & Efficiency in Diagnosis to Boost the Market Growth
4.2.1.2. Rising prevalence of cancer
4.2.2. Restraints and Challenges
4.2.2.1. Lack of Knowledge of AI Usage in the Healthcare Industry Might Hinder the Market Growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Artificial Intelligence in Cancer Diagnostics Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Artificial Intelligence in Cancer Diagnostics Market, by Application
5.1. Key Findings
5.2. Introduction
5.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Application, 2018 – 2030 (USD Million)
5.3. Screening & Diagnosis
5.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Screening & Diagnosis, by Region, 2018 – 2030 (USD Million)
5.4. Tumor Identification
5.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Tumor Identification, by Region, 2018 – 2030 (USD Million)
5.5. Surveillance
5.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Surveillance, by Region, 2018 – 2030 (USD Million)
5.6. Treatment
5.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Treatment, by Region, 2018 – 2030 (USD Million)

6. Global Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2018 – 2030 (USD Million)
6.3. Breast Cancer
6.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Breast Cancer, by Region, 2018 – 2030 (USD Million)
6.4. Prostate Cancer
6.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Prostate Cancer, by Region, 2018 – 2030 (USD Million)
6.5. Lung Cancer
6.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Lung Cancer, by Region, 2018 – 2030 (USD Million)
6.6. Colorectal Cancer
6.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Colorectal Cancer, by Region, 2018 – 2030 (USD Million)
6.7. Cervical Cancer
6.7.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Cervical Cancer, by Region, 2018 – 2030 (USD Million)
6.8. Others
6.8.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Others, by Region, 2018 – 2030 (USD Million)

7. Global Artificial Intelligence in Cancer Diagnostics Market, by End-Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2018 – 2030 (USD Million)
7.3. Hospitals
7.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Hospitals, by Region, 2018 – 2030 (USD Million)
7.4. Diagnostic centers
7.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Diagnostic centers, by Region, 2018 – 2030 (USD Million)
7.5. Medical Research Institute
7.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Medical Research Institute, by Region, 2018 – 2030 (USD Million)
7.6. Contract Research Organization
7.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Contract Research Organization, by Region, 2018 – 2030 (USD Million)
7.7. Other
7.7.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Other, by Region, 2018 – 2030 (USD Million)

8. Global Artificial Intelligence in Cancer Diagnostics Market, by Geography

9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/llyb9f

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716